Chun Feng
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A patient with myelodysplastic/myeloproliferative neoplasm with neutrophilia (MDS/MPN-N) harboring a DDX41 germline mutation: a case report.
Journal: Frontiers in oncology
Published: June 09, 2026
Reduced-Dose PTCy Plus Post-Engraftment Low-Dose ATG for GVHD Prophylaxis in Haploidentical PBSC Transplantation.
Journal: Transplantation and cellular therapy
Published: June 05, 2026
A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: April 24, 2026
Hypoplastic acute myeloid leukemia with aberrant lymphoid antigen expression and EWSR1::FEV fusion: A rare case report and literature review.
Journal: Therapeutic advances in hematology
Published: April 01, 2026
Isolated Myeloid Sarcoma of the Thoracic Spine as Initial Presentation of Acute Promyelocytic Leukemia: A Case Report and Literature Review.
Journal: Acta haematologica
Published: March 02, 2026
Safety and feasibility assessment of implantable chest wall venous access port for patients with acute leukemia.
Journal: Frontiers in oncology
Published: November 19, 2025
Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review.
Journal: Frontiers in immunology
Published: July 03, 2025
Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.
Journal: Chinese medical journal
Published: March 28, 2025
EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review.
Journal: Frontiers in immunology
Published: February 25, 2025
Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review.
Journal: Frontiers in immunology
Published: November 15, 2022
Last Updated: 09/26/2026